Mulay James

DirectorCG Oncology, Inc. (CGON) · full profile →Form 4 · filed Mar 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$125K
Net Open-Market Flow
-$125K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 16, 2026Option exercise(M)1K$12.59$16K1K
Mar 16, 2026Option exercise(M)654$3.72$2K654
Mar 16, 2026Sell(S)654$63.50$42K0
Mar 16, 2026Sell(S)1K$63.50$83K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 16, 2026Option exercise(M)654$0654
Mar 16, 2026Option exercise(M)1K$04K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-110831) within minutes of acceptance. Every field above traces to the original document. Verify it directly: